Different medication program of misoprostol as a cervical ripening agent before hysteroscopy

王芳,刘木彪,宗利丽,彭冬先
DOI: https://doi.org/10.3969/j.issn.1007-8622.2005.04.010
2005-01-01
Abstract:Objective:To evaluate the clinical effect of different medication program of misoprostol for cervical dilation before hysteroscopy. Methods: This was a prospective randomized study. GroupⅠ and groupⅡ:0.6 mg and 0.4 mg vaginal misoprostol;groupⅢ and groupⅣ:0.6 mg and 0.4 mg oral misoprostol. Cervical response, pain scores(VRS) , outcomes and complications of hysteroscopy were assessed. Results: The average cervical dilation were statistically different among the four groups (P0.01). There were no difference in operation time and the dosis of hysteropic fluid media among the four groups (P0.05). The average pain degree was no different between groupⅠ, groupⅡand groupⅢ(P0.05). The incidence of diarrhea and hypogastralgia in groupⅢ was significantly different compared with the other three groups(P0.05).Conclusion:0.4 mg vaginal misoprostol applied four hours before hysteroscopy is a satisfactory way for cervical pretreatment.
What problem does this paper attempt to address?